1. Fogelman I, Bessent RG, Turner RG, Citrin DL, Boyle IT, Greig WR: The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.J Nucl Med 19:270–275, 1978
2. Castronova FP, Guiberteau MJ, Berg G, McKusick KA, Callahan RJ, Potsaid MS: Pharmacokinetics of technetium-99m diphosphonate.J Nucl Med 18:809–814, 1977
3. Park CH, Glassman LM, Thompson NL, Mata JS: Reliability of renal imaging obtained incidentally in 99mTc-polyphosphate bone scanning.J Nucl Med 14:534–536, 1973
4. Hattner RS, Miller SW, Schimmel D: Significance of renal asymmetry in bone scans: experience in 795 cases.J Nucl Med 16:161–163, 1975
5. Vieras F, Boyd CM: Diagnostic value of renal imaging incidental to bone scintigraphy with99mTc-phosphate compounds.J Nucl Med 16:1109–1114, 1975